Clinical Trial Update: NSCLC Relapse Therapy After Surgery and Peri-operative Chemotherapy [Phase 3]

View source ↗

Summary

A Phase 3 trial investigating relapse therapy for non-small cell lung cancer after surgery and perioperative chemotherapy has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Intergroupe Francophone de Cancerologie Thoracique | Conditions: Carcinoma, Non-Small-Cell Lung | Phase 3 | Status: TERMINATED